LAIR-1 Suppresses Cell Growth of Ovarian Cancer Cell Via the PI3K-AKT-mTOR Pathway
Overview
Authors
Affiliations
Recently, over-expression of LAIR-1 has been found in some solid cancers, including ovarian cancer. The role of LAIR-1 in cancer progression needs further investigation. In this study, we identified the LAIR-1 cDNA sequence of the ovarian cancer cells HO8910. Using SKOV3 cells, we confirmed the finding from our previous study that LAIR-1 could suppress in vitro cell proliferation and cell migration. We also found LAIR-1 overexpression can induce apoptosis of SKOV3 cells. We revealed LAIR-1 suppressed cell growth by inhibiting the PI3K-AKT-mTOR axis. Moreover, the LAIR-1 antitumor activity and its mechanism were also identified in vivo. We used Co-IP assay and mass spectrometry to identify potential LAIR-1-binding proteins in LAIR-1 overexpressing SKOV3 cells. MS analysis identified 167 potentially interacting proteins. GO analyses indicated a possible involvement of LAIR-1 in mRNA processing through its interaction with some eukaryotic translation initiation factors (eIF4E1B, eIF2S3, eIF3D, eIF4G2, eIF5B) and eukaryotic translation elongation factors (eEF1A2 and eEF1B2). Our findings suggest that LAIR-1 may suppress the growth of ovarian cancer cells by serving as a modulator that suppresses PI3K-AKT-mTOR directly or regulating protein synthesis at the translational level. Our results indicate that a LAIR-1-based strategy may prevent or suppress the progression of ovarian cancer.
Mechanistic role of FN1 in LAIR-1 mediated downregulation of ovarian cancer cell proliferation.
Zhang H, Liu M, Zhong H, Ma L, Liu Y, Liu C BMC Cancer. 2025; 25(1):339.
PMID: 40000955 PMC: 11853514. DOI: 10.1186/s12885-025-13692-1.
Carey K, Young C, Clark A, Dammer E, Singh R, Lillard Jr J J Ovarian Res. 2024; 17(1):240.
PMID: 39627836 PMC: 11613732. DOI: 10.1186/s13048-024-01556-4.
Extracellular matrix remodeling in the tumor immunity.
Du W, Xia X, Hu F, Yu J Front Immunol. 2024; 14:1340634.
PMID: 38332915 PMC: 10850336. DOI: 10.3389/fimmu.2023.1340634.
Wei X, Pan S, Wang Z, Chen J, Lu L, Cao Q Cell Death Dis. 2023; 14(10):684.
PMID: 37845206 PMC: 10579300. DOI: 10.1038/s41419-023-06199-9.
Lin X, Liu Y, Zhang H, Wu L, Li Q, Deng J Cancer Cell Int. 2023; 23(1):208.
PMID: 37742009 PMC: 10518103. DOI: 10.1186/s12935-023-03047-w.